New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
08:07 EDTGHDXGenomic Health announces positive results of Oncotype DX in colon cancer
Genomic Health announced results from three studies of the Oncotype DX Colon Cancer test at the 2013 Gastrointestinal Cancers Symposium, including new data demonstrating that Recurrence Score results changed treatment recommendations in 45% of the enrolled stage II colon cancer patients. Presentations also include positive findings from a second health economics analysis suggesting that use of the test may result in a significant reduction in direct medical costs and improve patient well-being.
News For GHDX From The Last 14 Days
Check below for free stories on GHDX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
08:15 EDTGHDXGenomic Health announces two important international milestones
Genomic Health announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX breast cancer test in major German clinical guidelines. In Canada, the BC Cancer Agency in British Columbia agreed to fund the Oncotype DX breast cancer test for eligible patients, expanding reimbursement to more than 80% of the country's population. In Germany, updated guidelines from the AGO, or Gynecologic Oncology Working Group, now recommend the Oncotype DX breast cancer test as the only gene expression test to predict chemotherapy benefit in early-stage hormone receptor-positive invasive breast cancer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use